Latest News in the pharma Industry

Research & Development

Richter and Actavis Announce Positive Phase III Results for Cariprazine in the Prevention of Relapse in Patients with Schizophrenia

Richter and Actavis Announce Positive Phase III Results for Cariprazine in the Prevention of Relapse in Patients with Schizophrenia

21 Jan 2015

Read more 
Amgen Presents New Data Supporting First-Line Use of Vectibix in Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer

Amgen Presents New Data Supporting First-Line Use of Vectibix in Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer

19 Jan 2015

Read more 
Lilly and Merck Collaborate to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer

Lilly and Merck Collaborate to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer

15 Jan 2015

Read more 
BMS and Lilly Set to Collaborate to Evaluate Opdivo in Combination with Galunisertib in Advanced Solid Tumours

BMS and Lilly Set to Collaborate to Evaluate Opdivo in Combination with Galunisertib in Advanced Solid Tumours

14 Jan 2015

Read more 
Amgen and MD Anderson Announce Agreement to Develop BiTE Therapies for Myelodysplastic Syndrome

Amgen and MD Anderson Announce Agreement to Develop BiTE Therapies for Myelodysplastic Syndrome

13 Jan 2015

Read more 
Isarna Therapeutics Unveils New Selective TGF-beta Antagonist Program Targeting Multiple Indications in Ophthalmology

Isarna Therapeutics Unveils New Selective TGF-beta Antagonist Program Targeting Multiple Indications in Ophthalmology

12 Jan 2015

Read more 
Seattle Genetics and BMS Announce Clinical Collaboration to Evaluate Combination of Adcetris and Opdivo in Hematologic Malignancies

Seattle Genetics and BMS Announce Clinical Collaboration to Evaluate Combination of Adcetris and Opdivo in Hematologic Malignancies

12 Jan 2015

Read more 
HemoShear to Collaborate with Pfizer to Help Identify and Predict Drug-Induced Vascular Injury for Early-Stage Compounds

HemoShear to Collaborate with Pfizer to Help Identify and Predict Drug-Induced Vascular Injury for Early-Stage Compounds

12 Jan 2015

Read more 
Regeneron and Sanofi Announce Positive Topline Results from First Phase III Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia

Regeneron and Sanofi Announce Positive Topline Results from First Phase III Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia

9 Jan 2015

Read more 
Alkermes Phase II Results of ALKS 3831 Antipsychotic/Lower Weight Gain for Schizophrenia

Alkermes Phase II Results of ALKS 3831 Antipsychotic/Lower Weight Gain for Schizophrenia

8 Jan 2015

Read more 
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin Platform for Cancer Therapeutics

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin Platform for Cancer Therapeutics

7 Jan 2015

Read more 
Vectura Signs Global Development and Licence Agreement with Janssen in Asthma/COPD

Vectura Signs Global Development and Licence Agreement with Janssen in Asthma/COPD

6 Jan 2015

Read more